Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 6Enrolling by invitation 3Unknown 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Glioblastoma 81Brain Neoplasms 77Glioma 61Neoplasms 16Neuroblastoma 15Meningioma 14Medulloblastoma 13Neurofibromatosis 1 10Meningeal Carcinomatosis 9Ependymoma 9Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 8Neurologic Manifestations 6Diffuse Intrinsic Pontine Glioma 6Spinal Cord Neoplasms 5Recurrence 5Central Nervous System Neoplasms 5Astrocytoma 5Pheochromocytoma 4Paraganglioma 4Lung Neoplasms 4Sarcoma 3Rhabdoid Tumor 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Oligodendroglioma 3Neuroma, Acoustic 3Neurofibroma, Plexiform 3Head and Neck Neoplasms 3Ganglioneuroblastoma 3

Interventions

Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Parkinson Disease × CNS × Clear all
NCT06914427 2025-04-06

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

Xijing Hospital

Phase NA Not yet recruiting
35 enrolled
CNSGenitourinary

Glioma, Parkinson Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡